Dosage and administration
Apply to affected area once or twice daily
Apply to affected area once or twice daily
Sulfur 3%, Salicylic Acid 3%, Hydrocortisone 1%
SEBORRHEIC DERMATITIS CREAM
For relief of itching, scaling, redness, flaking and irritation associated with seborrheic dermatitis
FOR EXTERNAL USE ONLY.
Ask a doctor before use if condition covers a large area of the body
When using this product avoid contact with eyes. If contact occurs, rinse eye thoroughly with water
Stop use and consult a doctor if condition worsens or does not improve after regular use as directed
KEEP OUT OF REACH OF CHILDREN. If swallowed, seek medical advice or contact a Poison Control Center immediately
Apply to affected area once or twice daily
Aloe Oil, Carbomer, Ceteryl Alcohol, Coconut Oil, Extract of Aloe Vera, Glycerine, Glycol Sterate, Grapefruit Seed Extract, Polysorbate 20, Purified Water, Sodium Hydroxide, Sorbitol
Update drug facts
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1738574 | hydrocortisone 1 % / salicylic acid 3 % / sulfur 3 % Topical Cream | PSN | 9 |
| 1738574 | hydrocortisone 10 MG/ML / salicylic acid 30 MG/ML / sulfur 30 MG/ML Topical Cream | SCD | 9 |
| 1738574 | hydrocortisone 1 % / salicylic acid 3 % / sulfur 3 % Topical Cream | SY | 9 |
| Class | Version | Type | Effective |
|---|---|---|---|
| HYDROCORTISONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69683-202-11 | DERMOSCRIBE SEBORRHEIC DERMATITIS | 60 g in 1 BOTTLE | CREAM | 60 | 9 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69683-202 | 69683-202-11 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALOE | V5VD430YW9 | IACT |
| GRAPEFRUIT | O82C39RR8C | IACT |
| ALOE VERA LEAF OIL | JQ7YW886UQ | IACT |
| CETOSTEARYL ALCOHOL | 2DMT128M1S | IACT |
| CARBOMER HOMOPOLYMER TYPE C | 4Q93RCW27E | IACT |
| GLYCOL STEARATE SE | 6YLY96TQL6 | IACT |
| SORBITOL | 506T60A25R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| COCONUT OIL | Q9L0O73W7L | IACT |
| POLYSORBATE 20 | 7T1F30V5YH | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| WATER | 059QF0KO0R | IACT |
| SULFUR | 70FD1KFU70 | ACTIB |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| HYDROCORTISONE | WI4X0X7BPJ | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 8 | 2024-10-14 | full-release | 2026-06-01 00:35:32 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DERMOSCRIBE SEBORRHEIC DERMATITIS | SULFUR, SALICYLIC ACID, HYDROCORTISONE | DERMOSCRIBE PTY LTD | 2b6bf90b-5d42-4c08-afee-56e13122285e | 2025-10-17 | Warnings | 69683-202-11 69683-202 69683020211 4161aee0-5f36-1739-e063-6294a90a5bdf 2b6bf90b-5d42-4c08-afee-56e13122285e |
Adverse event summaries are temporarily unavailable. Other product information remains available.